Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 3
1989 2
2008 2
2009 3
2010 2
2011 3
2012 4
2013 2
2014 5
2015 5
2016 5
2017 4
2018 9
2019 11
2020 5
2021 7
2022 4
2023 3
2024 5
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75 results

Results by year

Filters applied: . Clear all
Page 1
Fuchs' dystrophy.
Wilson SE, Bourne WM. Wilson SE, et al. Cornea. 1988;7(1):2-18. Cornea. 1988. PMID: 3280235 Review.
Fuchs' dystrophy is an inherited disorder of unknown etiology in which the corneal endothelial cells develop morphologic and functional abnormalities. ...The definitive treatment for Fuchs' dystrophy is penetrating keratoplasty. Recent findings …
Fuchs' dystrophy is an inherited disorder of unknown etiology in which the corneal endothelial cells develop morphologi …
Imaging Fuchs Endothelial Corneal Dystrophy in Clinical Practice and Clinical Trials.
Patel SV. Patel SV. Cornea. 2021 Dec 1;40(12):1505-1511. doi: 10.1097/ICO.0000000000002738. Cornea. 2021. PMID: 34074894 Review.
Corneal tomography has an emerging role in the assessment of Fuchs endothelial corneal dystrophy (FECD) in clinical practice and potentially for future clinical trials. ...Tomographic imaging provides a functional assessment of corneal endothelial heal …
Corneal tomography has an emerging role in the assessment of Fuchs endothelial corneal dystrophy (FECD) in clinical pra …
Reply.
Patel SV, Hodge DO, Treichel EJ, Spiegel MR, Baratz KH. Patel SV, et al. Ophthalmology. 2020 Oct;127(10):e89. doi: 10.1016/j.ophtha.2020.04.042. Epub 2020 Jul 29. Ophthalmology. 2020. PMID: 32739194 No abstract available.
Reply.
Sun SY, Wacker K, Baratz KH, Patel SV. Sun SY, et al. Ophthalmology. 2019 Mar;126(3):e22. doi: 10.1016/j.ophtha.2018.10.011. Ophthalmology. 2019. PMID: 30803527 No abstract available.
TCF4-mediated Fuchs endothelial corneal dystrophy: Insights into a common trinucleotide repeat-associated disease.
Fautsch MP, Wieben ED, Baratz KH, Bhattacharyya N, Sadan AN, Hafford-Tear NJ, Tuft SJ, Davidson AE. Fautsch MP, et al. Prog Retin Eye Res. 2021 Mar;81:100883. doi: 10.1016/j.preteyeres.2020.100883. Epub 2020 Jul 28. Prog Retin Eye Res. 2021. PMID: 32735996 Free PMC article. Review.
Fuchs endothelial corneal dystrophy (FECD) is a common cause for heritable visual loss in the elderly. ...
Fuchs endothelial corneal dystrophy (FECD) is a common cause for heritable visual loss in the elderly. ...
Medical and Semi-surgical Treatments for Fuchs Endothelial Corneal Dystrophy.
Wacker K, Baratz KH, Fautsch MP, Patel SV. Wacker K, et al. Klin Monbl Augenheilkd. 2018 Jun;235(6):709-713. doi: 10.1055/a-0577-7953. Epub 2018 May 3. Klin Monbl Augenheilkd. 2018. PMID: 29723889 Review. English.
Unraveling the genetic mechanisms of Fuchs endothelial corneal dystrophy has opened new possibilities for future targeted medical therapy of the disease. ...
Unraveling the genetic mechanisms of Fuchs endothelial corneal dystrophy has opened new possibilities for future target …
Cancer Risk in Patients With Fuchs Endothelial Corneal Dystrophy.
Xu TT, Baratz KH, Fautsch MP, Hodge DO, Mahr MA. Xu TT, et al. Cornea. 2022 Sep 1;41(9):1088-1093. doi: 10.1097/ICO.0000000000002864. Epub 2021 Sep 27. Cornea. 2022. PMID: 35588167 Free PMC article.
PURPOSE: The purpose of this study is to quantify cancer risk in patients with Fuchs endothelial corneal dystrophy (FECD). METHODS: Using the 2014 to 2016 Medicare Limited 5% Data Sets-Carrier Line File, US Medicare fee-for-service beneficiaries (aged 65 year …
PURPOSE: The purpose of this study is to quantify cancer risk in patients with Fuchs endothelial corneal dystrophy (FEC …
Towards Clinical Trials in Fuchs Endothelial Corneal Dystrophy: Classification and Outcome Measures-The Bowman Club Lecture 2019.
Patel SV. Patel SV. BMJ Open Ophthalmol. 2019 Jul 11;4(1):e000321. doi: 10.1136/bmjophth-2019-000321. eCollection 2019. BMJ Open Ophthalmol. 2019. PMID: 31414054 Free PMC article. Review.
The surgical treatment of Fuchs endothelial corneal dystrophy (FECD) has advanced dramatically over the last two decades. Penetrating keratoplasty has been superseded by various iterations of endothelial keratoplasty, and currently, surgical removal of …
The surgical treatment of Fuchs endothelial corneal dystrophy (FECD) has advanced dramatically over the last two decade …
Visual Function in Pseudophakic Eyes with Fuchs' Endothelial Corneal Dystrophy.
Patel SV, Hodge DO, Treichel EJ, Baratz KH. Patel SV, et al. Am J Ophthalmol. 2022 Jul;239:98-107. doi: 10.1016/j.ajo.2022.01.016. Epub 2022 Feb 4. Am J Ophthalmol. 2022. PMID: 35123953
PURPOSE: To assess vision in pseudophakic eyes with Fuchs' endothelial corneal dystrophy (FECD) before the onset of clinically detectable corneal edema. ...
PURPOSE: To assess vision in pseudophakic eyes with Fuchs' endothelial corneal dystrophy (FECD) before the onset of cli …
Fuchs' Endothelial Corneal Dystrophy in Patients With Myotonic Dystrophy, Type 1.
Winkler NS, Milone M, Martinez-Thompson JM, Raja H, Aleff RA, Patel SV, Fautsch MP, Wieben ED, Baratz KH. Winkler NS, et al. Invest Ophthalmol Vis Sci. 2018 Jun 1;59(7):3053-3057. doi: 10.1167/iovs.17-23160. Invest Ophthalmol Vis Sci. 2018. PMID: 30025114 Free PMC article.
PURPOSE: RNA toxicity from CTG trinucleotide repeat (TNR) expansion within noncoding DNA of the transcription factor 4 (TCF4) and DM1 protein kinase (DMPK) genes has been described in Fuchs' endothelial corneal dystrophy (FECD) and myotonic dystrophy, …
PURPOSE: RNA toxicity from CTG trinucleotide repeat (TNR) expansion within noncoding DNA of the transcription factor 4 (TCF4) and DM1 protei …
75 results